期刊文献+

Fractalkine、IP-10及不同信号通路抑制剂对肿瘤微环境中NK细胞的影响 被引量:5

Effect of fractalkine, IP-10 and different signal pathway inhibitors on NK cells in the tumor microenvironment
下载PDF
导出
摘要 目的探讨Fractalkine(FKN)、干扰素诱导蛋白10(IP-10)以及不同信号通路抑制剂对肿瘤微环境自然杀伤(NK)细胞数目和功能的影响。方法免疫组化染色观察人乳腺癌组织中CD56和DAP10的分布情况。通过共培养小鼠巨噬细胞RAW 264.7与小鼠乳腺癌细胞4T1模拟体外肿瘤微环境(数目比例1:4),以小鼠NK细胞KY-1为研究对象。RTPCR检测肿瘤微环境中KY-1细胞表面活性受体CD16、NKG2D及NK1.1的表达;ELISA检测培养细胞上清CD107a的含量。在肿瘤微环境中加入10ng/ml FKN及10ng/ml IP-10,流式细胞术测定NK1.1+CD16+KY-1细胞的数量;趋化及黏附实验评价其迁移和黏附功能的变化。最后,以10nmol/L雷帕霉素、30μmol/L LY294002、500ng/μl穿心莲内酯、2μmol/L渥曼青霉素分别处理4T1细胞,收集上清分别孵育RAW 264.7细胞48h后,RT-PCR检测4T1、RAW 264.7 m RNA及两种混合m RNA中Rae1α、H60a的表达。结果肿瘤微环境中,KY-1细胞NK1.1+细胞比例、趋化率及黏附功能明显下降,加入FKN和IP-10后以上各项指标明显增高,不同信号通路阻滞剂使4T1细胞对NK细胞杀伤作用的敏感性均有不同程度提高,以雷帕霉素作用最为明显(P<0.05)。结论 FKN、IP-10可上调肿瘤微环境中NK细胞的数目和功能,雷帕霉素等通过诱导肿瘤细胞高表达NKG2D配体(Rae1、H60a),间接促进NK细胞的杀伤活性。 Objective To investigate the inducing effects of chemokines [fractalkine(FKN), IP-10] and different signal pathway inhibitors on NK cells in the tumor microenvironment(TME). Methods Immunohistochemistry was performed using antibodies for CD56 and DAP10 respectively on human breast carcinoma. Murine macrophages(RAW 264.7) and breast cancer cells(4T1) were co-cultivated at a 1:4 ratio to imitate the TME with NK cells(KY-1) set as the object. RT-PCR was used to determine the m RNA expressions of CD16, NKG2 D and NK1.1, and the content of CD107 a in the supernatants was determined by ELISA. 10ng/ml FKN and 10ng/ml IP-10 were added into the TME, NK1.1+CD16+KY-1 cells were counted with flow cytometry, migration and adhesion assays were used to assess the related function of KY-1 cells. 4T1 cells were incubated in 10nmol/L of rapamycin, 30μmol/L of LY294002, 500ng/μl of andrographolide and 2mmol/L of wortmannin, the 4T1 tumor supernatants(TSNs) were harvested separately and used to incubate RAW 264.7 for 48 h, then the expressions of Rae1α and H60 a m RNA in 4T1, RAW 264.7 and their mixture were determined by RT-PCR. Results The related indicators of KY-1 cells such as NK1.1+ number, chemotaxis rate, and adhesion function decreased obviously in TME, and the above indices increased after the addition of FKN and IP-10, and some signal pathway inhibitors indirectly promoted NK cells' function in TME, and among them rapamycin was the most efficient one(P〈0.05). Conclusion FKN and IP-10 may up-regulate the number and function of NK cells in TME, and rapamycin can promote NK cells' killing function by inducing high expression of NKG2DLs(Rae1, H60a) on tumor cells.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2015年第7期547-553,共7页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金(81171975) 天津市应用基础与前沿技术研究计划(15JCYBJC26900)~~
关键词 趋化因子CX3CL1 趋化因子CXCL10 信号传导 杀伤细胞 天然 肿瘤微环境 chemokine CX3CL1 chemokine CXCL10 signal transduction killer cells natural tumor microenvironment
  • 相关文献

参考文献17

  • 1Fidler IJ. Timeline - The pathogenesis of cancer metastasis: the ‘seed and soil' hypothesis revisited [J]. Nat Rev Cancer, 2003, 3(6): 453-458.
  • 2刘建平,朱静,田杰,刘官信,鲁荣,林建萍.肿瘤微环境中过表达的IL-6对大鼠间充质干细胞恶性转化的影响[J].解放军医学杂志,2012,37(10):930-934. 被引量:10
  • 3Bolovan-Fritts CA, Spector SA. Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction[J]. Blood, 2008, 111(1): 175-182.
  • 4Zhang Y, Gao Z, Wang D, et al. Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP- 10[J].J Neuroinflammation, 2014, 11: 79.
  • 5王青山,倪虹,魏晓丽,李玉皓,向荣,王悦.IL-6对M1型巨噬细胞向肿瘤相关M2型巨噬细胞转化过程的诱导作用[J].解放军医学杂志,2009,34(8):927-931. 被引量:8
  • 6臧怡雯,周易明,陈宗祐.NKG2D及其配体在肿瘤免疫中的研究进展[J].复旦学报(医学版),2011,38(4):367-371. 被引量:11
  • 7Zitvogel L, Kroemer G. Cytokines reinstate NK cell-mediated cancer immunosurveillance[J]. J Clin Invest, 2014, 124(11): 4687-4689.
  • 8Sarkar S, Germeraad WTV, Rouschop KMA, et al. Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells [J]. Pone, 2013, 8(5): e64835.
  • 9周智锋,江金华,李洁羽,陈强,叶韵斌.IL-12诱导肝癌微环境中NK细胞活化发挥抗肿瘤作用[J].中国肿瘤生物治疗杂志,2013,20(1):93-98. 被引量:15
  • 10Albertsson PA, Basse PH, Hokland M, et al. NK cells and the turnout microenvironment: implications for NK-cell function and anti-tumour activity[J]. Trends Immunol, 2003, 24(11): 603-609.

二级参考文献123

  • 1李俭杰,张毅,张明伟,侯春梅,吴英,毛宁,艾辉胜.小鼠H-2半相合非清髓同种异基因造血干细胞移植模型的建立及其相关研究[J].中国实验血液学杂志,2004,12(5):655-660. 被引量:3
  • 2李晓峰,叶德富,陈强.肿瘤的异基因免疫治疗研究现状[J].福建医科大学学报,2005,39(B08):64-66. 被引量:1
  • 3陈强,李晓峰,叶韵斌,范南峰,黄伟炜,陈明水,李洁羽,陈慧菁,陈淑萍,周智锋.MHC半相合脾加骨髓细胞诱发H22荷瘤鼠的抗肿瘤效应[J].中国肿瘤生物治疗杂志,2006,13(2):107-111. 被引量:5
  • 4Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: A clinical path to effective cancer immunotherapy [J]. Nat Rev Cancer, 2008, 8(4) : 299-308.
  • 5Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment [J]. J Natl Cancer Inst, 2005, 97(19) : 1407-1427.
  • 6Rugged L, Caparmi M, Casucci M, Volpi I, Tosti A, Perruccio K, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation [ J ]. Blood, 1999, 94(1) : 333-339.
  • 7Sutlu T, Alici E. Natural killer cell-based immunotherapy in cancer: Current insights and future prospects [ J ]. J Intern Med, 2009, 266(2) : 154-181.
  • 8Suarez-Alvarez B, Lopez-Vazquez A, Baltar JM, Ortega F, Lopez-Larrea C. Potential role of NKG2D and its ligands in organ transplantation: New target for immunointervention [ J ]. Am J Transplant, 2009, 9(2) : 251-257.
  • 9Roetynek S, Baratin M, Johansson S, Lemmers C, Vivier E, Ugolini S. Natural killer cells and malaria [J]. Immunol Rev, 2006, 214 : 251-263.
  • 10Vidal-Castineira JR, Lopez-Vazquez A, Diaz-Pena R, Alonso- Arias R, Martinez-Borra J, Perez R, et al. Effect of killer immunolobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection [ J ]. J Virol, 2010, 84( 1 ) : 475-481.

共引文献52

同被引文献30

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部